0001209191-15-075102.txt : 20151009
0001209191-15-075102.hdr.sgml : 20151009
20151009171638
ACCESSION NUMBER: 0001209191-15-075102
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151007
FILED AS OF DATE: 20151009
DATE AS OF CHANGE: 20151009
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BOGER JOSHUA S
CENTRAL INDEX KEY: 0001197023
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 151153964
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-10-07
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197023
BOGER JOSHUA S
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2015-10-07
4
M
0
10400
35.64
A
355684
D
Common Stock
2015-10-07
4
S
0
900
107.23
D
354784
D
Common Stock
2015-10-07
4
S
0
4300
108.74
D
350484
D
Common Stock
2015-10-07
4
S
0
1300
109.60
D
349184
D
Common Stock
2015-10-07
4
S
0
2500
110.67
D
346684
D
Common Stock
2015-10-07
4
S
0
1400
111.93
D
345284
D
Common Stock
13286
I
401(k)
Common Stock
122700
I
Common Stock held in trust
Stock Option (right to buy)
35.64
2015-10-07
4
M
0
10400
0.00
D
2016-02-01
Common Stock
10400
167200
D
Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $107.23 (range $106.92 to $107.69).
Open market sales reported on this line occurred at a weighted average price of $108.74 (range $108.20 to $109.11).
Open market sales reported on this line occurred at a weighted average price of $109.60 (range $109.24 to $110.23).
Open market sales reported on this line occurred at a weighted average price of $110.67 (range $110.24 to $111.09).
Open market sales reported on this line occurred at a weighted average price of $111.93 (range $111.52 to $112.42).
Fully vested.
Omar White, Attorney-In-Fact
2015-10-09